Kabonk, Thank you for your detailed correction
Post# of 148264
Thank you for your detailed correction of my false assumptions of the trial imaging techniques and your explanation of the NASH landscape.
Of course, I’ll know expect your expert observations as additional detail as of the NASH trial are released.
Any thoughts on why the open label patients were administered 350 mg and the double blinded cohort 700 mg?